Skip to main content
Caplight Logo









CreatSens Health

CreatSens Health

Private
ReusHealthcare & Life Scienceshttps://renalyse.com/

Last Round

Seed

Oct 9, 2023

Total Funding Raised

$1.19M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

CreatSens Health is a healthtech company that develops a point-of-care device for creatinine and potassium determination in blood and a technological platform for renal monitoring.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Health IoT, Telemedicine

Business Model

B2B

Customer Profile

Usage-Based SaaS, Hardware + Subscription, Hardware Sales, Government Contracts

AI Layer

Application

Keywords

point-of-care diagnosticschronic kidney diseaseCKDPOC diagnosticsat-home testingmedical deviceremote patient monitoringRPMkidney function testbiomarker analysistelehealthcreatinine monitoringpotassium monitoringdiagnostic consumablesMedTechdigital healthHealth IoT

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CreatSens Health Comparables

Compare CreatSens Health with similar companies based on industry and business-model similarity.

CreatSens Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CardioRenal
85%
Kalium Health
85%
Jana Care
83%

CreatSens Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 9, 2023
AcceleratorMay 14, 2019

Key People

Founding team and executive leadership

Marta Novell Recasens

Co-Founder & CTO

Founding Team

Tomàs Guinovart

Co-Founder & COO

Founding Team

CreatSens Health Investors

Notable investors and investment history

CreatSens Health investors
InvestorRounds
Eurostars SME programmeSeed
GENESIS VenturesSeed, Accelerator
BStartup Banco SabadellAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 14, 2026

    Grew 30% QoQ from 10 to 13 employees.

  • Oct 9, 2023

    $1.05M raised from fundacionbotin-org and GENESIS Ventures.

CreatSens Health Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

CreatSens Health Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CreatSens Health's valuation, stock price, and market status.

Firmographic Details

HeadquartersReus
Employee Range11
Year Founded2017
Last FundingOct 9, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?